115
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Changes in Bone Mineral Density Following Conventional Oral Phosphonate Treatment of Hypophosphatemic Osteomalacia: A Non-Randomized Controlled Study

, , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , & show all
Pages 7925-7931 | Published online: 08 Nov 2021

References

  • Kinoshita Y, Fukumoto S. X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases: prospect for new treatment. Endocr Rev. 2018;39(3):274–291. doi:10.1210/er.2017-00220
  • Bockenhauer D, Bokenkamp A, Van’t Hoff W, et al. Renal phenotype in Lowe syndrome: a selective proximal tubular dysfunction. Clin J Am Soc Nephrol. 2008;3(5):1430–1436. doi:10.2215/CJN.00520108
  • Bergwitz C, Roslin NM, Tieder M, et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet. 2006;78(2):179–192. doi:10.1086/499409
  • Shanbhogue VV, Hansen S, Jorgensen NR, Beck-Nielsen SS. Impact of conventional medical therapy on bone mineral density and bone turnover in adult patients with X-linked hypophosphatemia: a 6-year prospective cohort study. Calcif Tissue Int. 2018;102(3):321–328. doi:10.1007/s00223-017-0363-3
  • Sullivan W, Carpenter T, Glorieux F, Travers R, Insogna K. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. J Clin Endocrinol Metab. 1992;75(3):879–885.
  • Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26(7):1381–1388. doi:10.1002/jbmr.340
  • Bhambri R, Naik V, Malhotra N, et al. Changes in bone mineral density following treatment of osteomalacia. J Clin Densitom. 2006;9(1):120–127. doi:10.1016/j.jocd.2005.11.001
  • Jeong HJ, Lee JM, Lee TH, et al. Two cases of hypophosphatemic osteomalacia after long-term low dose adefovir therapy in chronic hepatitis B and literature review. J Bone Metab. 2014;21(1):76–83. doi:10.11005/jbm.2014.21.1.76
  • Saghafi M, Azarian A, Hashemzadeh K, Sahebari M, Rezaieyazdi Z. Bone densitometry in patients with osteomalacia: is it valuable? Clin Cases Miner Bone Metab. 2013;10(3):180–182.
  • Arthur S, Chopra A. Familial hypophosphatemia: an unusual presentation with low back ache, heel pain, and a limp in a young man, and literature review. Clin Rheumatol. 2011;30(4):585–589. doi:10.1007/s10067-010-1607-z
  • Negri AL, Bogado CE, Zanchetta JR. Bone densitometry in a patient with hypophosphatemic osteomalacia. J Bone Miner Metab. 2004;22(5):514–517. doi:10.1007/s00774-004-0516-0
  • El-Desouki MI, Othman SM, Fouda MA. Bone mineral density and bone scintigraphy in adult Saudi female patients with osteomalacia. Saudi Med J. 2004;25(3):355–358.
  • El-Desouki M, Al-Jurayyan N. Bone mineral density and bone scintigraphy in children and adolescents with osteomalacia. Eur J Nucl Med. 1997;24(2):202–205. doi:10.1007/BF02439554
  • Cosman F, Schnitzer MB, McCann PD, Parisien MV, Dempster DW, Lindsay R. Relationships between quantitative histological measurements and noninvasive assessments of bone mass. Bone. 1992;13(3):237–242. doi:10.1016/8756-3282(92)90203-9
  • Fukumoto S. The role of bone in phosphate metabolism. Mol Cell Endocrinol. 2009;310(1–2):63–70. doi:10.1016/j.mce.2008.08.031
  • Martin A, David V, Quarles LD. Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev. 2012;92(1):131–155. doi:10.1152/physrev.00002.2011
  • Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. J Clin Invest. 1985;75(6):1858–1868. doi:10.1172/JCI111900
  • Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab. 2010;95(4):1846–1850. doi:10.1210/jc.2009-1671
  • Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121(11):4393–4408. doi:10.1172/JCI46122